Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0002085679-25-000004

Options or other derivatives

  • Chief Business Officer acquired 255,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Beer Caroline Stark Chief Business Officer 2025-10-01 Grant or award · Non-Qualified Stock Option (right to buy) +255,000 255,000 D
Loading xslF345X05/edgardoc.xml…